Pharma’s Productivity Problem: Finding More Blockbuster Drugs
Xconomy
AUGUST 16, 2016
What Booth didn’t say explicitly is that providing only a limited supply of drug candidates in the face of increasing demand is a key element in the venture investment model. With a limited supply of new firms coming into the business, venture’s ability to expand to meet demand is inherently constrained.
40 
Let's personalize your content